By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Velcura Therapeutics, Inc. 

4300 Varsity Drive, Suite D

Ann Arbor  Michigan  48108  U.S.A.
Phone: N/A Fax:



Start Up

Company News
Velcura Therapeutics, Inc. to Begin Clinical Trials in Rheumatoid Arthritis Patients 1/7/2009 8:27:43 AM
Velcura Therapeutics, Inc. Adds William Brinkerhoff to its Board of Directors 7/21/2008 11:09:46 AM
Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy 5/12/2008 10:49:35 AM
President and CEO of Velcura Therapeutics, Inc. Named the 2008 Grant Thornton Leader and Innovator of the Year 5/9/2008 7:10:49 AM
Velcura Therapeutics, Inc. Teams with International Discovery Sourcing Consultants 2/4/2008 7:47:44 AM
Velcura Therapeutics, Inc. Can Begin Clinical Trials Following Successful Investigational New Drug Application to U.S. FDA 1/28/2008 10:07:22 AM
Velcura Therapeutics, Inc. Appoints Industry Executive to Lead Regulatory Affairs 10/15/2007 10:34:27 AM
Former Pfizer Inc. (PFE) Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics, Inc. Inflammatory Disease Initiatives 10/4/2007 8:28:43 AM
NIST Awards $2 Million to Velcura Therapeutics, Inc. for Innovative Technology R&D Dual-Action Therapies for Bone Disease 9/28/2007 7:40:24 AM
Velcura Therapeutics, Inc. Reports Positive Pre-IND Meeting With FDA and Plans Early Clinical Trials for New Drug to Treat Multiple Myeloma Bone Disease 9/24/2007 7:50:37 AM